Correlation between coronary artery calcium score and aortic diameter in a high-risk population of elderly male hypertensive patients. by �솉洹몃（ et al.
Correlation between coronary artery calcium score and aortic 
diameter in a high-risk population of elderly male hypertensive 
patients
In-Jeong Choa, Ran Heoa,c,d, Hyuk-Jae Changa,b, Sanghoon Shina, Chi Young Shima, Geu-
Ru Honga, James K. Minc,d, and Namsik Chunga
aDivision of Cardiology, Department of Internal Medicine, Severance Hospital, Seoul, Republic of 
Korea
bSeverance Biomedical Science Institute, Yonsei University College of Medicine, Yonsei 
University Health System, Seoul, Republic of Korea
cDepartment of Radiology, Weill Cornell Medical College and the New York-Presbyterian 
Hospital, New York, New York, USA
dDepartment of Medicine, Weill Cornell Medical College and the New York-Presbyterian Hospital, 
New York, New York, USA
Abstract
Background—Studies on the relationship between coronary artery calcium and aortic diameter 
are scarce. The aim of the current study was to evaluate the correlation between coronary artery 
calcium score (CACS) and maximal thoracic and abdominal aortic diameters in a population of 
elderly (>65 years) male hypertensive patients at high risk for coronary artery disease.
Patients and methods—From June 2012 to April 2013, we prospectively enrolled 393 male 
hypertensive patients older than 65 years of age who had no history of aortic aneurysm. Coronary 
artery calcium and maximal diameters of the ascending thoracic aorta (ATAmax), descending 
thoracic aorta (DTAmax), and abdominal aorta (AAmax) were measured using noncontrast 
computed tomography imaging. Aortic diameters are indexed to body surface area (BSA). 
Participants were divided into five groups according to CACS (0, 1–10, 10–100, 100–400, and > 
400).
Results—The mean ATAmax/BSA, DTAmax/BSA, and AAmax/BSA were 22.0 ± 2.7, 16.3± 1.9, 
and 13.0± 2.9 mm, respectively. On multivariate analysis, ATAmax/BSA was associated 
independently with age, diabetes, and history of aortic valve replacement (all P < 0.001). 
DTAmax/BSA was associated independently with age (P < 0.001). However, there were no 
significant correlations between thoracic aorta diameter and CACS. In contrast, AAmax/BSA was 
associated independently with CACS as well as age and history of smoking (P = 0.014, 0.003, and 
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0.019, respectively). Abdominal aortic aneurysm (>30 mm) was more prevalent in patients with a 
CACS of 400 or more compared with the others (14 vs. 3%, P < 0.001).
Conclusion—CACS was associated with increased abdominal aorta diameter, but not with 
thoracic aorta diameter. Therefore, screening for an abdominal aortic aneurysm is warranted in 
patients with a high risk of coronary artery disease and a high CACS. However, the necessity for 
thoracic aortic aneurysm screening is not clear in these patients.
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Introduction
Early detection of an aortic aneurysm is important in patients at high risk because of its life-
threatening potential. These aneurysms are typically asymptomatic until rupture, which can 
be catastrophic; therefore, reliable screening for patients at risk is critical [1]. Some studies 
have reported that abdominal aortic (AA) aneurysms are more prevalent in patients 
undergoing cardiac catheterization for coronary artery disease (CAD) or awaiting coronary 
artery bypass grafting [2,3]. As both conditions share common risk factors and 
pathophysiological substrates [4], we hypothesized that there is an association between AA 
aneurysm and CAD. Ascending thoracic aortic (ATA) aneurysms have a different etiology 
from AA aneurysms and most often result from cystic medial degeneration [1]. This process 
occurs normally to some extent with aging and is accelerated by hypertension [5], both of 
which are known risk factors for CAD. However, the relationship between CAD and 
thoracic aortic aneurysm has not been clearly defined.
It has been reported that coronary artery calcium is strongly related to the presence of 
coronary atherosclerotic plaques [6,7], and a high coronary artery calcium score (CACS) on 
screening computed tomography (CT) in an asymptomatic person portended a very high risk 
for coronary events [8]. Therefore, CACS measured on a screening noncontrast CT has been 
used widely to identify patients at high risk for CAD in asymptomatic populations [9].
Coronary artery calcification and aortic aneurysm share similar risk factors including 
advanced age and hypertension, and they both require screening in asymptomatic patients. 
In addition, they can be obtained simultaneously using a noncontrast CT scan. However, 
data on the relationship between CACS and aortic diameter are scarce. Therefore, our aim 
was to determine whether CACS correlates with aortic diameter in elderly male patients 
with hypertension, who are at high risk for atherosclerosis and CAD.
Patients and methods
Study population
We prospectively enrolled 542 consecutive patients from June 2012 to April 2013 at the 
outpatient clinic of Severance Cardiovascular Hospital (Seoul, Republic of Korea). All 
patients were male hypertensive patients older than 65 years of age without a history of 
aortic aneurysm. We excluded 30 patients with suboptimal CT images and 119 patients with 
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a history of coronary artery stent revascularization in whom an accurate CACS could not be 
calculated because of the presence of coronary stents. The remaining 391 patients comprised 
the study population. This study was approved by our institutional review board and 
informed consent was obtained from all patients.
Measurement of clinical variables
Data on a history of hypertension, diabetes, smoking, and aortic valve replacement (AVR) 
were obtained from medical records. Height, weight, and blood pressure were measured 
during the initial patient visit. Serum calcium, phosphorus, total cholesterol, low-density 
lipoprotein-cholesterol, high-density lipoprotein-cholesterol, triglyceride, and serum 
creatinine level were measured after a minimum 12-h fasting period. Hypertension was 
defined as systolic blood pressure 140 mmHg or more and/or diastolic blood pressure 90 
mmHg or more or treatment with antihypertensive agents. Diabetes was defined as treatment 
with hypoglycemic agents or insulin, or fasting glucose 126 mg/dl or more. Dyslipidemia 
was defined as any one of the following: total cholesterol 240 mg/dl or more, low-density 
lipoprotein-cholesterol 130 mg/dl or more, high-density lipoprotein-cholesterol 40 mg/dl or 
less, triglyceride 150 mg/dl or more, and/or treatment with lipid-lowering agents. Ever-
smoking was defined as having smoked for more than 1 year.
Computed tomography imaging protocol and analysis
All examinations were performed on a 320-row CT system (Aquilion ONE; Toshiba 
Medical Systems, Otawara, Japan) with patients positioned supine on the table. Dual 
scanograms were used for planning the examination and determining the anatomical range 
to be covered. Multiple volumes were placed to cover the entire aorta from above the aortic 
arch to the aortic bifurcation. Patients underwent aortic CT with a prospective ECG-gating 
wide-volume protocol (from four to six volumes, according to body height). Data were 
obtained from 40 to 50% of the R–R interval. The CT gantry rotation time was 350 ms. The 
tube voltage was 120 kV and the effective tube current was adjusted using the adaptive 
iterative dose reduction three-dimensional (AIDR 3D) algorithm. The resulting four to six 
individual volume data sets were automatically stitched together immediately after 
reconstruction to generate one CT data set of the entire aorta. All data were reconstructed 
using a standard soft-tissue and lung kernel (FC43). Images were reconstructed with a slice 
thickness of 0.5 mm. The CT angiography data sets were reconstructed at 45% of R–R 
intervals. CACS acquisition was performed in a single gantry rotation during breath hold at 
inspiration, which allows image reconstruction at a single cardiac phase. The tube voltage 
was 120 kV and the effective tube current was adjusted using the AIDR 3D algorithm.
Systemic measurements of the ascending and descending thoracic aorta (ATAPAB and 
DTAPAB) were performed at the outer aortic wall perpendicular to the axis of the aorta in 
the axial plane at the lower level of the pulmonary artery bifurcation (Fig. 1a). After 
measuring ATAPAB and DTAPAB, maximal ascending thoracic aorta diameter (ATAmax) 
was measured in the axial plane from just above the aortic root to the aortic arch 
perpendicular to the axis of the aorta. Similarly, the maximal descending thoracic aorta 
diameter (DTAmax) was measured at the descending thoracic aorta (DTA) distal from the 
aortic arch to the diaphragm level of the thoracic aorta in the same axis. We reassessed 
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ATAmax and DTAmax in the sagittal and coronal planes using reconstructed images (Fig. 1c 
and d) to avoid slicing through the aorta off-axis, which would result in a falsely large 
diameter [1]. Aortic diameter at the superior mesenteric artery (AASMA) was measured at 
the first slice inferior to the origin of the superior mesenteric artery in the axial plane (Fig. 
1b). Maximal abdominal aortic diameter (AAmax) was defined as the maximal diameter of 
the AA from the diaphragm to the first slice superior to the aortic bifurcation. Aortic 
diameters were indexed to body surface area (BSA).
Coronary scans were used to identify each focus of calcification with a minimal density of 
130 HU and a minimal voxel size of 1.03 mm3 along the course of the coronary artery. For 
each calcified focus, a score was calculated according to the volume score methods. The 
volume score was calculated using the interpolation method described by Callister et al. 
[11]. The volume score measures the volume of the calcium by the density factor. The sum 
of all patient scores constituted the total CACS. Participants were categorized on the basis of 
the CACS in the following manner: CACS = 0, 0 < CACS ≤ 10, 10 < CACS ≤ 100, 100 < 
CACS ≤ 400, and CACS > 400.
Statistical analysis
The distribution for all relevant variables was reported either as a percentage or as the mean 
± SD. The groups were compared using χ2 statistics for categorical variables. One-way 
analysis of variance was used to compare the differences in aortic diameters according to the 
CACS. To determine independent correlates of maximal aortic diameters, linear 
relationships were assessed by simple linear regression analysis. Variables with a P-value 
less than 0.2 on univariate analysis were entered into the multiple linear regression model. A 
P-value of less than 0.05 was considered statistically significant.
Results
The demographic and clinical characteristics of all patients enrolled in this study are shown 
in Table 1. The mean age of the patients was 73 years. Diabetes and dyslipidemia were 
diagnosed in 30 and 58% of the patients, respectively, and ~70% had a history of smoking. 
The mean ATAmax/BSA, DTAmax/BSA, and AAmax/BSA were 22.0 ± 2.7, 16.3 ± 1.9, and 
13.0 ± 2.9 mm, respectively. Aortic diameters according to CACS are shown in Table 2. 
There were no significant differences in ATAPAB/BSA, ATAmax/BSA, DTAPAB/BSA, and 
DTAmax/BSA among the CACS groups. However, AASMA/BSA and AAmax/BSA increased 
significantly as the CACS increased (P for trend = 0.017 and 0.002, respectively). Figure 2 
shows the individual ATAmax/BSA, DTAmax/BSA, and AAmax/BSA values in the study 
population. Most patients (55/56, 98%) with a CACS of 0 had an AAmax of 30 mm or less, 
with the exception of one patient, who had an AAmax of 40 mm.
Figure 3 shows the prevalence of abdominal aortic aneurysm according to the CACS. On the 
basis of a reported maximum diameter of 20mm of normal infrarenal aorta, AA aneurysm is 
more commonly defined as a maximum diameter of greater than 30 mm [12]. When patients 
were categorized into two groups (CACS ≤ 400 and CACS > 400), abdominal aneurysm 
(AAmax > 30 mm) [12] was more prevalent in patients with a CACS of 400 or more (14 vs. 
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3%, P < 0.001). However, the overall prevalence of AA aneurysm 50–59 mm was low 
(0.5%, 2/393) and all belonged to the CACS more than 400 group.
Table 3 shows the results of the regression analysis of variables for determinants of maximal 
aorta diameters. On multivariate analysis, ATAmax/BSA diameter was associated 
independently with age, diabetes, and a history of AVR (all P < 0.001), and DTAmax/BSA 
was associated independently with age (P < 0.001). However, there were no significant 
correlations between thoracic aortic diameters and CACS. In contrast, AAmax/BSA was 
associated independently with CACS, as well as age and history of smoking (P = 0.014, 
0.003, and 0.019).
Discussion
The principal findings of the current study are that (i) CACS was associated with increased 
AA diameter, but not with the diameters of the ATA and DTA, and (ii) the prevalence of 
AA aneurysm was greatest in patients with a CACS of 400 or more.
Arterial calcium development is strongly associated with vascular injury and atherosclerotic 
plaque formation [13]. The prevalence of coronary artery calcium reflects the prevalence of 
coronary atherosclerosis, and calcification of the coronary arteries occurs in approximate 
proportion to the severity and extent of coronary atherosclerosis [14]. According to a meta-
analysis by Pletcher et al. [15], the risk of major CAD events increases 2.1-fold and 10-fold 
for scores ranging from 1–100 to 400, respectively, as compared with scores of 0. Therefore, 
noncontrast CT screening for detection of CACS is currently recommended in asymptomatic 
intermediate-risk patients and low-risk patients with a family history of premature coronary 
heart disease to assess the burden of coronary atherosclerosis [9].
From the current study, we found that CACS was significantly associated with AA diameter, 
as we hypothesized on the basis of the common pathophysiology of coronary calcification 
and AA aneurysm. Patients with a CACS over 400 had an AA aneurysm prevalence up to 
14%, which was much higher than that in other patients (3%). CAD and AA aneurysm share 
many of the same atherosclerotic risk factors, although their causes are diverse. Several 
previous studies have addressed the relationship between CAD and AA aneurysm. 
Significant CAD was found in 33% of patients who were already scheduled for surgical 
correction of an AA aneurysm [16]. The prevalence of AA aneurysm was 14% in elderly 
patients with CAD, which was much higher than that in age-matched controls (3%) [4]. The 
present study population included male hypertensive patients older than 65 years of age who 
were at high risk for CAD. More than 70% had a history of smoking more than 1 year in 
their lifetime. However, the overall prevalence of AA aneurysm, which has been reported to 
be associated with a high annual rupture risk of 6.5% [17], was very low (0.5%) and patients 
with a high rupture risk (AA aneurysm diameter of 50–59 mm) all belonged to the CACS of 
400 or more subgroup. These findings suggest that screening of the AA to rule out aneurysm 
might be worth considering in patients with CACS of 400 or more who have a high CAD 
risk.
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Although aging and hypertension are also known common risk factors for both ATA 
aneurysm and atherosclerosis, there were no differences in ATA and DTA among the CACS 
groups. Cystic medial degeneration, the pathophysiology of aneurysm, and dilation of the 
ATA is associated with the aging process and is known to be accelerated by hypertension 
[5]. Nevertheless, CACS, which reflects coronary atherosclerosis, was not associated with 
thoracic aorta dilation in the current study.
This result is consistent with the notion that, in contrast to AA aneurysms, ATA aneurysms 
are not considered to be the result of atherosclerosis [18], and they are usually a clinical 
component of heritable connective tissue disorders such as Marfan syndrome, Ehlers–
Danlos syndrome, and bicuspid aortic valve [19,20].
In this study, 3.8% of patients had a history of AVR, and AVR was an independent 
determinant of ATA diameter in addition to age and BSA. Patients who undergo AVR are 
often reported to have some degree of ascending aortic dilation because of poststenotic 
aortic dilation or aortic regurgitation [21], but the natural history of ATA dilation following 
AVR is not certain. The incidence of aortic valve disease is increasing worldwide because of 
the aging population [22]. Optimal screening strategies for ATA aneurysms in elderly 
patients with aortic valve disease should be discussed in further studies.
Limitations
The data comprise a population of elderly male patients with hypertension, and therefore the 
results cannot directly be applied to low-risk populations or women. Measurement of aortic 
diameter by noncontrast CT in the transverse plane may not be representative of the true 
short axis; thus, a contrast CT study may be required. However, we reassessed our 
measurements in the sagittal and coronal planes using reconstructed images to avoid slicing 
through the aorta off-axis. The prevalence of smoking history was high in the population 
studied and the current guidelines recommend that elderly male patients with a smoking 
history have an indication for AA aneurysm screening. Therefore, the vast majority of 
patients should be screened irrespective of CACS. However, as CACS showed a significant 
correlation even after adjusting for smoking history, further large studies in a population of 
low smoking prevalence would help to clarify the association between CACS and AA 
aneurysm. Aortic volume would be more reliable than diameter as it has been reported that 
in patients with untreated aortic aneurysm, a change in aortic volume could occur in the 
absence of a significant change in maximal diameter [23]. Therefore, further studies using 
aortic volume would be more helpful to define the precise relation between CACS and aortic 
size.
Conclusion
CACS was associated with increased AA diameter, but not with the ATA and DTA. 
Screening of the AA to rule out an aneurysm might be worth considering in patients at high 
risk of CAD who have a CACS more than 400. However, the necessity for thoracic aortic 
aneurysm screening is not clear in those patients.
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Fig. 1. 
Measurement of aortic diameters. (a) Ascending and descending thoracic aorta at the 
pulmonary artery bifurcation (PAB) and (b) abdominal aorta at the superior mesenteric 
artery (SMA) in the axial plane. The maximal diameter of ascending and descending 
thoracic aorta was remeasured in the sagittal (c) and coronal planes (d) using reconstructed 
images [10]. AA, abdominal aorta; ATA, ascending thoracic aorta; DTA, descending 
thoracic aorta.
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Fig. 2. 
Correlation between aortic diameters and coronary artery calcium score: (a) ascending 
thoracic aorta, (b) descending thoracic aorta, and (c) abdominal aorta. ATAmax, maximal 
ascending thoracic aorta diameter; AAmax, maximal abdominal aorta diameter; BSA, body 
surface area; DTAmax, maximal descending thoracic aorta diameter.
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Fig. 3. 
Prevalence of abdominal aortic (AA) aneurysm according to coronary artery calcium score 
(CACS).
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Table 1
Clinical characteristics of the study population
Variables Value (n = 393)
Age (years) 73 ± 5
Male [n (%)] 393 (100)
Height (cm) 166.6 ± 7.5
Weight (kg) 67.2 ± 9.4
BSA (m2) 1.76 ± 0.14
Systolic blood pressure (mmHg) 126 ± 15
Diastolic blood pressure (mmHg) 74 ± 10
Hypertension [n (%)] 393 (100)
Diabetes mellitus [n (%)] 118 (30.0)
Dyslipidemia [n (%)] 229 (58.3)
Ever smoked [n (%)] 277 (70.5)
Aortic valve replacement [n (%)] 15 (3.8)
Medications [n (%)]
  Diuretics 100 (25.4)
  β-Blocker 161 (41.0)
  ACEi/ARB 280 (71.3)
  Calcium channel blocker 724 (61.8)
Laboratory findings (g/ml)
  Calcium 9.0 ± 0.4
  Phosphorus 3.4 ± 0.6
  Creatinine 1.2 ± 1.1
  Total cholesterol 154.1 ± 31.6
  LDL-cholesterol 90.6 ± 28.9
  HDL-cholesterol 44.2 ± 11.4
ACEi, angiotensin-converting enzyme inhibitor; ARB, aldosterone receptor blocker; BSA, body surface area; HDL, high-density lipoprotein; LDL, 
low-density lipoprotein.
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Table 3
Linear regression analysis of variables as determinants of maximal aortic diameters
Univariate Multivariate
Variables β P-value β P-value
ATAmax/BSA
  Age 0.203 < 0.001 0.196 < 0.001
  Diabetes mellitus − 0.137 < 0.001 − 0.177 < 0.001
  Dyslipidemia − 1.937 0.053 − 0.069 0.146
  AVR 0.221 < 0.001 0.199 < 0.001
  Ever-smoking − 0.058 0.256 – –
  CACS 0.005 0.924 – –
DTAmax/BSA
  Age 0.249 < 0.001 0.244 < 0.001
  Diabetes mellitus − 0.082 0.104 − 0.076 0.120
  Dyslipidemia − 0.089 0.079 − 0.067 0.170
  AVR 0.049 0.022 0.093 0.055
  Ever-smoking 0.018 0.722 – –
  CACS − 0.027 0.598 – –
AAmax/BSA
  Age 0.102 0.043 0.149 0.003
  Diabetes mellitus − 0.026 0.614 – –
  Dyslipidemia 0.030 0.550 – –
  AVR 0.008 0.869 – –
  Ever-smoking 0.127 0.013 0.118 0.019
  CACS 0.189 0.003 0.125 0.014
AAmax, maximal abdominal aorta diameter; ATAmax, maximal ascending thoracic aorta diameter; AVR, aortic valve replacement; BSA, body 
surface area; CACS, coronary artery calcium score; DTAmax, maximal descending thoracic aorta diameter.
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